PMS43 Cost-Effectiveness of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in the Treatment of Severe Active RA

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1398
https://www.valueinhealthjournal.com/article/S1098-3015(12)03111-7/fulltext
Title : PMS43 Cost-Effectiveness of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in the Treatment of Severe Active RA
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03111-7&doi=10.1016/j.jval.2012.08.1398
First page : A447
Section Title : Muscular-Skeletal Disorders
Open access? : No
Section Order : 898
Categories :
Tags :
Regions :
ViH Article Tags :